Welcome to our dedicated page for LanzaTech Global news (Ticker: LNZA), a resource for investors and traders seeking the latest updates and insights on LanzaTech Global stock.
LanzaTech Global, Inc. develops carbon management and conversion technologies built around a proprietary gas-fermentation platform. The company uses microbes to transform waste carbon, industrial off-gases and waste-based feedstocks into ethanol, energy products, chemicals and materials, with recurring updates tied to sustainable aviation fuel, renewable diesel and other carbon-to-value pathways.
Company news covers commercial deployments, pilot operations, project contracts, technology partnerships, grant-supported development, financing activity and quarterly or annual operating results. Updates also include LanzaTech’s non-controlling ownership position in LanzaJet, Alcohol-to-Jet technology exposure, and international project activity across markets such as Asia and Europe.
LanzaTech Global (LNZA)/b) announced that CEO Dr. Jennifer Holmgren was featured on the Water Tower Research Small-Cap Spotlight podcast, hosted by Tim Gerdeman. The discussion offers investors an in-depth overview of LanzaTech’s biofermentation technology, which converts industrial waste gas into ethanol for use in sustainable aviation fuel, marine fuel, and chemicals targeting what the company describes as a multi-trillion dollar global market.The company said the podcast also covers its shift from a pure licensing model to owning and operating its own projects, supported by more than $500 million from Brookfield, recent European certification expected to open higher-value EU/UK opportunities, and key milestones anticipated over the next 12–18 months, including the first Brookfield project transfer, FID and construction launches on projects in the UK and Belgium, and initial marine-fuel use of its recycled carbon ethanol. A webcast link is to be available on LanzaTech’s investor relations website, and the podcast will also be posted on Water Tower Research’s YouTube page.
LanzaTech (NASDAQ: LNZA) reported second-quarter 2026 revenue of $9.0 million, down 1% year over year, with cost reduction efforts driving a 67% decline in operating expenses to $11.7 million and a 74% improvement in Adjusted EBITDA loss to $(7.6) million.
Net income was $184.3 million versus a $32.5 million loss, primarily from a $208.1 million non-cash unrealized gain on the SGLT investment following its Hong Kong IPO. Cash and restricted cash rose to $48.9 million, supported by a $50 million common stock issuance. The company reintroduced guidance, targeting 2026 revenue of $50–$55 million and full‑year Adjusted EBITDA loss of $(22)–$(26) million, and highlighted progress on the FLITE SAF project and ISCC EU certification for recycled carbon fuels.
LanzaTech (NASDAQ: LNZA) has been added to the Russell 3000 Index, effective at the open of the U.S. market on June 29, 2026, as part of the 2026 Russell indexes reconstitution.
This also places LanzaTech in the Russell 2000 small-cap index, expanding visibility with institutional investors and passive index funds.
LanzaTech (NASDAQ: LNZA) announced that joint venture Beijing Shougang LanzaTech Technology completed an IPO of 40 million H-shares on the Hong Kong Stock Exchange at about US$1.86 per share, raising roughly US$75 million and implying a US$750 million market cap.
After the IPO, LanzaTech holds 33,520,231 H-shares, or about 8.38% of the JV. The JV runs four facilities using LanzaTech technology, with annual revenue of about US$77–87 million from 2023–2025, supporting growth in waste-derived ethanol and sustainable aviation fuel (SAF).
LanzaTech (NASDAQ: LNZA) will release its second quarter 2026 financial results before U.S. markets open on Friday, August 14, 2026. A conference call is scheduled for 8:30 a.m. Eastern Time, with access via live webcast and telephone.
The webcast will be hosted in the Events and Presentations section of LanzaTech’s investor relations website and archived for twelve months. A telephone replay will be available until 11:59 p.m. Eastern Time on August 28, 2026.
LanzaTech (NASDAQ: LNZA) entered a securities purchase agreement with institutional investors for a registered direct offering of 2,000,000 common shares, targeting ~$20 million gross proceeds before fees.
The offering, under an effective Form S-3 shelf, is expected to close on or about May 18, 2026, with proceeds for general corporate purposes.
LanzaTech (NASDAQ: LNZA) reported Q1 2026 revenue of $12.0 million, up from $9.5 million in Q1 2025. Net loss narrowed to $14.7 million and Adjusted EBITDA loss to $7.9 million. Operating expenses fell 59% to $13.5 million.
The company closed $20 million in equity financing in January and received $10 million in May, with the option for up to an additional $20 million through May 2027. Management now believes recent capital raises and cost actions alleviate prior substantial doubt about its going concern status.
Operationally, LanzaTech won a contract for a 24K MTA advanced biofuel plant in India, selected a UK site for its Dragon II SAF project, and achieved guaranteed performance at a Japan MSW‑ethanol facility. LanzaJet completed a $47 million Series A at a $650 million pre‑money valuation, reducing LanzaTech’s stake to about 46%.
LanzaTech (NASDAQ: LNZA) has selected North Sea Port, Ghent, Belgium as the site for Europe’s first commercial Alcohol-to-Jet sustainable aviation fuel (SAF) facility using the LanzaJet ATJ process. The €500 million FLITE project targets annual output of 79,000 tonnes of SAF and 9,000 tonnes of renewable diesel.
The facility is expected to create about 50 permanent jobs and an average of 300 FTE roles over three years of construction. Front-End Engineering Design is largely complete, site control secured, feedstock LOIs and offtake frameworks are in place, and an EIA scoping notification is being submitted.
BRIGHT (DTU) and LanzaTech (NASDAQ: LNZA) signed a multi-year partnership through April 2028 to design and install a next-generation C1 biofoundry at DTU. The collaboration provides a non-exclusive license to LanzaTech biofoundry workflows and aims to accelerate gas-fermentation R&D converting CO, CO₂ and methane into fuels, chemicals and materials.
The biofoundry will combine automation, AI, robotics and specialized gas-handling for high-throughput strain development, enabling faster Design–Build–Test–Learn cycles and shared research access across Denmark and Europe.
LanzaTech (NASDAQ: LNZA) reported Q4 2025 revenue of $28.0M and full-year revenue of $55.8M, with net loss improving to $49.0M and adjusted EBITDA loss of $71.3M for 2025. Operating expenses fell 21% to $104.5M for the year; Q4 operating expenses declined 45% to $18.3M.
The company completed a $20M private placement, secured a €40M EU Innovation Fund grant, and saw changes in LanzaJet ownership (finalized 53% non-controlling interest then reduced to ~46% after a Series A transaction).